FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program
http://www.fda.gov/news-events/press-announcements/fda-provides-update-external-evaluation-strengthen-agencys-tobacco-program

http://www.fda.gov/medical-devices/medical-device-recalls/2022-medical-device-recalls

FDA Roundup: December 16, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-16-2022

FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-high-risk-non-muscle-invasive-bladder-cancer

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-hold-advisory-committee-meeting-discuss-future-vaccination-regimens

http://www.fda.gov/medical-devices/medical-device-recalls/teleflex-and-arrow-international-llc-recall-arrow-mac-two-lumen-central-venous-access-and-pressure

Olipudasa alfa ((XenpozymeTM) para la deficiencia de esfingomielinasa ácida
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1402184

FDA Roundup: December 13, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-13-2022

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-recall-three-detect-covid-19-test-lots

http://www.fda.gov/medical-devices/letters-health-care-providers/2020-letters-health-care-providers